Diffuse Intrinsic Pontine Gliomas: Treatments and Controversies
Overview
Authors
Affiliations
Diffuse intrinsic pontine gliomas (DIPGs) are a fairly common pediatric brain tumor, and children with these tumors have a dismal prognosis. They generally are diagnosed within the first decade of life, and due to their location within the pons, these tumors are not surgically resectable. The median survival for children with DIPGs is less than 1 year, in spite of decades of clinical trial development of unique approaches to radiation therapy and chemotherapy. Novel therapies are under investigation for these deadly tumors. As clinicians and researchers make a concerted effort to obtain tumor tissue, the molecular signals of these tumors are being investigated in an attempt to uncover targetable therapies for DIPGs. In addition, direct application of chemotherapies into the tumor (convection-enhanced delivery) is being investigated as a novel delivery system for treatment of DIPGs. Overall, DIPGs require creative thinking and a disciplined approach for development of a therapy that can improve the prognosis for these unfortunate children.
Solst S, Mapuskar K, Graham C, King S, Rheem R, Current K Radiat Res. 2023; 200(5):456-461.
PMID: 37758035 PMC: 10759934. DOI: 10.1667/RADE-23-00006.1.
Murdaugh R, Anastas J Front Pharmacol. 2023; 14:1002296.
PMID: 37205910 PMC: 10191214. DOI: 10.3389/fphar.2023.1002296.
Gene Therapy for High Grade Glioma: The Clinical Experience.
Varela M, Comba A, Faisal S, Argento A, Franson A, Barissi M Expert Opin Biol Ther. 2022; 23(2):145-161.
PMID: 36510843 PMC: 9998375. DOI: 10.1080/14712598.2022.2157718.
Van Gool S, Makalowski J, Bonner E, Feyen O, Domogalla M, Prix L Medicines (Basel). 2020; 7(5).
PMID: 32438648 PMC: 7281768. DOI: 10.3390/medicines7050029.
Liu Y, Liu H, Zhang D Oncol Lett. 2018; 16(5):6401-6406.
PMID: 30405776 PMC: 6202498. DOI: 10.3892/ol.2018.9461.